间质性肺异常的综合综述
间质性肺异常(ILA)指未怀疑间质性肺病(ILD)个体中与间质过程相容的影像学改变,患病率在肺癌筛查和人群队列中为2.5%至16.7%。ILA与死亡率相关,进展在20%至76%病例中发生于2至6年随访内,临床处理需基于影像、范围及临床生理发现进行风险分层。
要点
- ILA患病率在肺癌筛查和人群队列中为2.5%至16.7%。
- ILA与死亡率相关,进展在20%至76%病例中发生于2至6年随访内。
- 临床处理需基于影像特征、受累范围及临床生理发现进行风险分层。
核心结论
- ILA是未怀疑ILD个体中与间质过程相容的影像学改变,与死亡率相关,需风险分层区分无后果的影像发现与早期ILD。
研究设计与样本
- 综述总结了ILA的患病率、危险因素、进展、相关生物标志物及临床管理策略。
主要发现
- ILA患病率在肺癌筛查和人群队列中为2.5%至16.7%。
- ILA进展在20%至76%病例中发生于2至6年随访内。
- 危险因素包括年龄较大、吸烟及MUC5B等基因多态性。
临床怎么用
- 临床处理ILA需基于影像特征、受累范围及临床生理发现进行风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Interstitial lung abnormalities (ILAs) represent radiological entities that comprise changes compatible with an interstitial process, occurring in individuals not suspected to have interstitial lung disease (ILD). The prevalence of ILAs ranges from 2.5% to 16.7% in lung cancer screening and population-based cohorts. ILAs have consistently been associated with mortality. Risk factors include older age, smoking, and genetic polymorphisms such as MUC5B. Progression of ILAs occurs in 20%-76% of cases over 2-6 years of follow-up. The clinical approach to ILAs involves risk stratification based on radiological features, extent of involvement, and associated clinical and physiological findings. ILAs pose a significant challenge in distinguishing inconsequential radiological findings from early ILD. This review summarises the current understanding of ILAs, including prevalence, risk factors, progression, associated biomarkers, and clinical management strategies.
引用
- Moodley Y, Mackintosh JA. A Comprehensive Review of Interstitial Lung Abnormalities. Respirology. 2025. PMID: 40090879. doi:10.1111/resp.70026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。